DrAndrew Kaunitz

A Phase III, multi-center, open label, randomized parallel group study evaluating the proportion of post-menarchal women with complete resolution of nonatypical endometrial hyperplasia treated with Mirena or oral progestin for 6 months

COllaboration for EQuity in Uterine Leiomyomas

A multicenter, open-label, controlled study to investigate the effect of LF111 on bone mineral density (BMD) in adolescent and adult women in comparison with non-users of hormonal contraceptive methods.

A multicenter, open-label, controlled study to investigate the effect of LF111 on bone mineral density (BMD) in adolescent and adult women in comparison with non-users of hormonal contraceptive methods

A Phase 3, Multicenter, Open-Label, Single Arm Study of MR-100A-01 in Women of Childbearing Potential to Evaluate Contraceptive Efficacy and Safety

A double-blind, randomized, placebo-controlled multicenter study to investigate efficacy and safety of elinzanetant for the treatment of vasomotor symptoms over 52 weeks in postmenopausal women

A Phase 3, Open-Label, Multi-Center, Single-Arm Study to Assess Contraceptive Efficacy and Safety of the Etonogestrel (MK-8415) Implant During Extended Use From 3 Years After Insertion in Females 35 Years of Age or Younger

Phase 2, Multicenter, Double-blind (Sponsor-unblinded), Randomized, Placebo-Controlled Study of the Safety and Efficacy of Elagolix in Women with Polycystic Ovary Syndrome

A Randomized Double-blind Placebo Controlled Phase 3 Trial to Evaluate the Efficacy and Safety of Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort Study II)

An International Phase 3 Double-Blind, Placebo-controlled, Randomized Withdrawal Study of Relugolix Coadministered with Estradiol and Norethindrone Acetate in Women with Heavy Menstrual Bleeding Associated with Uterine Fibroids

A Phase 3, Multicenter, Open-Label Study of a Levonorgestrel 52 mg Intrauterine System for the Treatment of Heavy Menstrual Bleeding

An International Phase 3 Open-Label, Single-Arm, Long Term Efficacy and Safety Extension Study to Evaluate Relugolix Co Administered with Low-Dose Estradiol and Norethindrone Acetate in Women with Heavy Menstrual Bleeding Associated with Uterine Fibroids

Acurian ForSite Master Services Agreement

The development of Phase 3 clinical protocol, assessing the safety and efficacy of LILETTA in the treatment of Heavy Menstrual Bleeding (“HMB”).

A Single-Arm, Phase III, Open-Label, Multicenter, Study in Women aged 18-35 Years of the Contraceptive Efficacy And Safety of Amphora® Contraceptive Vaginal Gel

Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double-Blind and Randomized Phase III Study of 24-Week Intravaginal Prasterone)

FemBlocTM Permanent Contraceptive System

An International Phase 3 Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study to Evaluate Relugolix Co-Administered with and without Low-Dose Estradiol and Norethindrone Acetate in Women with Heavy Menstrual Bleeding Associated with Uterine Fibroids

Multi-center, open-label, uncontrolled study to assess contraceptive efficacy and safety of Mirena during extended use beyond 5 years in women 18 to 35 years of age including a subgroup evaluation of a treatment effect on heavy menstrual bleeding

Prospective, Non-Interventional/Observational Registry of US Uterine Fibroids Patients

A Multicenter, Open-label, Single-Arm Study to Evaluate the Contraceptive Efficacy and Safety of a Combined Oral Contraceptive Containing 15 mg Estetrol and 3 mg Drospirenone

A Double-blind, Randomized, Parallel-group, Placebo-controlled Study of MLE4901 for the Treatment of Polycystic Ovary Syndrome (PCOS)

A Phase II, Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Proof of Concept Study with an Interim Futility Analysis of Epelsiban in Patients with Adenomyosis

A RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED DOSE RANGING STUDY TO EVALUATE THE SAFETY AND EFFICACY OF RAD1901 IN....

A PHASE III SINGLE ARM CLINICAL TRIAL TO STUDY THE CONTRACEPTIVE EFFICACY AND SAFETY OF THE MK-8342B...........